Amy Yang is senior legal consultant in the Mergers and Acquisitions practice group. Her practice focuses on mergers and acquisitions, general corporate, foreign direct investment, employment, regulatory matters and private equity.
Amy has more than ten years' experience in advising multinational companies in the area of China inbound investment, including asset and equity acquisitions, green-field investment, joint ventures, divestitures and other corporate restructuring. Amy has advised clients from a wide range of industries with their acquisitions and investments in China, such as auto, chemical, food, health care, paper, computer software, equipment and hotel management.
In addition, Amy has extensive experience in the regulatory and compliance matters with respect to investment and operation in China, including incorporation, permits and licenses, employment, environment, foreign exchange and real estate.
Magna International Inc., a leading automotive manufacturer and supplier, on its acquisition of a majority stake in HLZX Group, a leading automotive seats supplier in China.
Nestlé Waters, the no.1 bottled water company worldwide, on the sale of its water business in the mainland China to Tsingtao Brewery Group Company Limited, China’s second-largest beer maker.
Magna Steyr, an international automotive contract manufacturer, in its joint ventures with Beijing Electric Vehicle Co., Ltd.
Grupo Bimbo, an international bakery headquartered in Mexico, in its acquisition of Mankattan Group's bakery business in China.
IHI Corporation, a Japanese industrial group listed on the Tokyo Stock Exchange, in the sale of its small-block diesel engine business to Caterpillar Inc.
Huhtamaki Oyj, a global specialist in packaging for food and drink with a network of 77 manufacturing units and 24 sales offices in altogether 34 countries, in its acquisition of American pulp and paper company, International Paper's paper cup business in China.
A German car manufacturer's Trucks and Buses Division in the regulatory and compliance matters relating to type approval, emission control and other matters.
Alvotech, a new player in the field of biopharmaceuticals, in its cooperation and joint venture with Changchun High & New Technology Industries (Group) Inc.
Rewalk, a Nasdaq listed company with wearable robotic exoskeleton as key products, in its cooperation with Realcan Pharmaceutical Co. Ltd., a China-based medical service provider.